Viralgen Vector Core

Luisa Amoedo, Chief Operating Officer

Oct. 11 | 3:15pm | Oxford Biomedica Ballroom 

San Sebastian, Spain 

(Private) 

In-person Presentation 

Viralgen is a CDMO born as a joint venture between AskBio and Columbus Venture Partners, combining decades of technology and drug development experience in multiple platforms to support best-in-class service offerings to the gene therapy market. We specialize in the production of rAAV viral vectors. Our optimized facility in San Sebastian, Spain maximizes throughput and efficiency of our proprietary Pro10™ suspension manufacturing platform. This enables industry-leading scalability, reproducibility, and speed to market. Through our superior technology platform, we deliver industry-leading titers and cGMP-certified quality for all AAV serotypes to our client partners, optimize the cost-of-goods and accelerate clinical development and commercialization of life-saving genetic medicines. 

www.viralgenvc.com 



By using this website you agree to accept our Privacy Policy and Terms & Conditions